Affimed (AFMD) Prices 22.5M Share Offering at $4/sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. CDNS
2. AVGO
3. SPY
4. META
5. ANT
6. AAPL
7. JBLU
8. SSD
9. AMKR
10. AGYS

Go back to Affimed (AFMD) Prices 22.5M Share Offering at $4/sh

Affimed Announces Pricing of Upsized $90 Million Public Offering of Common Shares

April 12, 2022 10:02 PM EDT

HEIDELBERG, Germany, April 12, 2022 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (Affimed or the Company), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the pricing of its previously announced public offering of 22,500,000 of its common shares at a public offering price of $4.00 per common share. In addition, Affimed has granted the underwriters a 30-day over-allotment option to purchase up to 3,375,000 common shares at the public offering price less underwriting discounts. After deducting the underwriting discounts, the net proceeds of the public offering are expected... More